Cologuard (EXAS): Net earnings per share (EPS TTM)
The complexity of maintaining sterile laboratories at Exact Sciences (EXAS) contrasts with the high efficiency of its automated biomaterial analysis systems. The current trailing twelve-month EPS helps balance these factors, with the parameter stabilizing at -1.09. Business stability is complemented by an environmental approach based on the safe disposal of reagents and energy-efficient facilities.
Financial and market metric breakdowns for Exact Sciences Corp (EXAS)
- current quotes and average value forecast:
- stock exchange capitalization data:
- business book valuation details:
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Exact Sciences|EXAS - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Cologuard|EXAS - Company Aggregate Debts|Debts to Book Capitalization Exact Sciences Corporation|EXAS - Company Long-Term Liabilities|Company Current Liabilities Exact Sciences|Quick Liquidity Indicator exactsciences.com
- earnings and multiples data:
EXAS - Final Profit|Expected Profit Exact Sciences|EXAS - Business Payback Period|Forward P/E Multiple Exact Sciences Corporation|EXAS - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Exact Sciences Corporation|EXAS - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Exact Sciences|EXAS - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months exactsciences.com|EXAS - Earnings per share growth this year|Earnings growth forecast for next year Exact Sciences
Analysis of all company metrics:Exact Sciences (EXAS)
Net income per share (TTM) measures the company's total net income over the last twelve months, allocated per common share to evaluate the actual return on equity. By analyzing the trend of fundamental TTM earnings per share, an investor can see the impact of financial reports on the capitalization of Exact Sciences (EXAS) during a period of aggressive diagnostic platform implementation and the market expansion of new oncology tests.
Competitor analysis
A - Earnings per share for the last twelve months|Net earnings per share for the last four quarters questdiagnostics.com DGX|ILMN: Net earnings per share (EPS TTM)|RVTY - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Bio-Rad Laboratories Inc|Anbio Corp (NNNN) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) SHC|QDEL - Net earnings per one share for the last twelve months|OPKO Health - Net earnings per share for the last 12 months|CDNA: Earnings per share for the last 12 months|Maravai LifeSciences Corp - Net earnings per share (EPS TTM)|FLGT - Net earnings per share (EPS TTM)|LAB: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months cytekbio.com|Net earnings per share for the last 12 months OSUR|XGN (Exagen Diagnostics) - Earnings per share for the last four quarters|Net earnings per share for the last 12 months MDXH (MDxHealth Inc.)|LUCD (Lucid Diagnostics, Inc) - Earnings per share for the trailing year|Earnings per share for the last twelve months Prenetics PRE|Net earnings per share for the last four quarters Insight Molecular Diagnostics, Inc. (IMDX)|Trinity Biotech Corp - Net earnings per share (EPS TTM)|ProPhase Labs Inc (PRPH) - Net earnings per share for the last 12 months|AIMD: Net earnings per share (EPS TTM)|CODX - Net earnings per share for the last four quarters|HSCS (Heart Test Laboratories) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months biomerica.com BMRA|Earnings per share for the last twelve months Cardio Diagnostics (CDIO)|Onconetix Inc - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) VRAX (Virax Biolabs Group Ltd)|BJDX - Net earnings per share for the last 12 months|Aspira Women's Health - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months acceleratediagnostics.com|Centogene N.V. (CNTG) - Earnings per share for the last twelve months|ENZ - Net earnings per share for the last four quarters|FRES (Fresh2 Group Ltd) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months GTG Labs GENE|Net earnings per share for the last 12 months ME (23andMe Holding Co.)|psychemedics.com - Earnings per share for the last 12 months
